Wednesday, 18 September 2019

Biologics News

  • Cell death pioneer wins Agilent thought leader award

    Biologics |  Influencers | By BioSpectrum Bureau  | 0 Comment | 11 Dec, 2013

    Singapore: Dr Junying Yuan, a pioneer and leading researcher in the field of cell death at the Chinese Academy of Sciences, has received an Agilent Thought Leader award in recognition of he...Read more

  • Samsung to make Roche biologics at Korean plant

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Oct, 2013

    Singapore: Samsung BioLogics and Roche have entered into a long term strategic manufacturing agreement under which Samsung will manufacture Roche's proprietary commercial biologic medicines...Read more

  • Sanofi begins biopharmaceutical plant construction

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2014

    Singapore: Sanofi and US-based Transgene have launched the construction phase of the manufacturing platform dedicated to the production of viral vectors, such as Transgene's MUC1 targeted c...Read more

  • Coherus starts ph3 trial of rheumatoid arthritis biosimilar drug

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    ‎Singapore: US based biosimilar therapeutic developer, Coherus BioSciences, has started its Phase 3 trial of CHS-0214, an investigational etanercept biosimilar for rheumatoid arthriti...Read more

  • Biologics' demand will boost cell culture, stem cell market

    Biologics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 14 Nov, 2012

    Singapore: Cell culture is going to become the next big pharmaceutical trend, as laboratories rush to meet demand for stem cell and biologics, states a new report by healthcare experts GBI ...Read more

  • Austrianova starts cell bank for cancer therapy

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Mar, 2013

    Singapore: Austrianova Singapore has established a research cell bank, the first step towards late-phase clinical trials in patients with advanced inoperable pancreatic cancer, as well as a...Read more

  • Genzyme to invest $80 mn to boost Fabrazyme production

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 17 Oct, 2013

    Singapore: Genzyme, a Sanofi company, plans to invest USD80 million to build a new downstream processing facility for Fabrazyme (agalsidase beta) to expand purification capacity to support ...Read more

  • Australian academy of science gets new council members

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Nov, 2012

    Singapore: Internationally-recognized experts in computing and atmospheric physics, developmental biology, organometallic chemistry and evolutionary genetics have been elected to join the A...Read more

  • China marches ahead with regulatory approvals

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 07 Mar, 2012

    After five years of amendments and two rounds of public consultations, the State Food and Drug Administration (SFDA) issued Good Manufacturing Practice for Drugs that came into effect on Ma...Read more

  • Ranbaxy to market infliximab biosimilar

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jan, 2014

    Singapore: Switzerland based EPIRUS, a wholly-owned subsidiary of Boston-based EPIRUS Biopharmaceuticals, and Ranbaxy Laboratories, a division of Daiichi Sankyo Company, Tokyo, have signed ...Read more

  • David Johnston to lead PPD's lab services

    Biologics |  Influencers | By BioSpectrum Bureau  | 0 Comment | 09 Aug, 2013

    Singapore: Pharmaceutical Product Development (PPD) has appointed Dr David Johnston as executive vice president of global laboratory services.Dr Johnston is to direct PPD's laboratory servi...Read more

  • Agilent, Korea institute to launch neurometabolomics center

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 28 Oct, 2013

    Singapore: Agilent Technologies and Korea-based Daegu Gyeongbuk Institute of Science and Technology (DGIST) have collaborated to launch DGIST's new Neurometabolomics Excellence Research Cen...Read more

  • Shire biologics facility gets FDA clearance

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Feb, 2014

    Singapore: Shire, global specialty biopharmaceutical company, has recieved US FDA approval for production of VPRIV drug substance (velaglucerase alfa for injection) in Shire's manufacturing...Read more

  • MedImmune, UCSF enter 3-year R&D deal

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Feb, 2014

    Singapore: MedImmune, the global biologics R&D arm of AstraZeneca, has entered into a three-year collaboration with the Clinical and Translational Science Institute (CTSI) at the Univer...Read more

  • D A Prasanna is ACRO India's new Chairman

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jan, 2014

    Singapore: On January 10 2014, members of Association of Contract Research Organizations (ACRO INDIA) met and Mr D A Prasanna was elected unanimously as the Chairman of the Association. He ...Read more

  • India announces new biosimilar regulatory guidelines

    Biologics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2012

    Boston: India has announced the much-awaited new and simple regulatory guidelines for similar biologics which have been approved and marketed in USA or Europe for more than four years. Th...Read more

  • Aussie's CardioCel gets US approval

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 11 Feb, 2014

    Singapore: Australia based Admedus has received FDA clearance to market CardioCel in the US. CardioCel is the group's lead regenerative tissue product to repair and treat a range of cardio...Read more

  • Asia biologics manufacturers face the 'quality challenge'

    Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 07 Mar, 2012

    Biologics manufacturers in Asia have to be more vigilant and give higher priority to product safety and product efficacy. Even though countries like India and China can lower manufacturing ...Read more



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls